Scott Gottlieb’s surprise March 5 announcement that he would be stepping down from his role as US FDA Commissioner took industry insiders by surprise. Take a look back at Gottlieb’s accomplishments during his brief, 22-month tenure in the position, find out what’s next for the agency, and discover what his departure means for several major initiatives currently in the pilot phase, as Medtech Insight takes you behind the headlines and into the impact of the news affecting the medtech industry.